Corrigendum: Safety of Semaglutide
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Frontiers Media S.A.
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/1d6095bb78274de5a98922ae3f3ed6df |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| id |
oai:doaj.org-article:1d6095bb78274de5a98922ae3f3ed6df |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:1d6095bb78274de5a98922ae3f3ed6df2021-11-10T15:21:04ZCorrigendum: Safety of Semaglutide1664-239210.3389/fendo.2021.786732https://doaj.org/article/1d6095bb78274de5a98922ae3f3ed6df2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fendo.2021.786732/fullhttps://doaj.org/toc/1664-2392Mark M. SmitsDaniël H. Van RaalteFrontiers Media S.A.articleglucagon-like peptide-1 receptor agonist (GLP-1RA)oralsubcutaneoussemaglutidetype 2 diabetessafetyDiseases of the endocrine glands. Clinical endocrinologyRC648-665ENFrontiers in Endocrinology, Vol 12 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
glucagon-like peptide-1 receptor agonist (GLP-1RA) oral subcutaneous semaglutide type 2 diabetes safety Diseases of the endocrine glands. Clinical endocrinology RC648-665 |
| spellingShingle |
glucagon-like peptide-1 receptor agonist (GLP-1RA) oral subcutaneous semaglutide type 2 diabetes safety Diseases of the endocrine glands. Clinical endocrinology RC648-665 Mark M. Smits Daniël H. Van Raalte Corrigendum: Safety of Semaglutide |
| format |
article |
| author |
Mark M. Smits Daniël H. Van Raalte |
| author_facet |
Mark M. Smits Daniël H. Van Raalte |
| author_sort |
Mark M. Smits |
| title |
Corrigendum: Safety of Semaglutide |
| title_short |
Corrigendum: Safety of Semaglutide |
| title_full |
Corrigendum: Safety of Semaglutide |
| title_fullStr |
Corrigendum: Safety of Semaglutide |
| title_full_unstemmed |
Corrigendum: Safety of Semaglutide |
| title_sort |
corrigendum: safety of semaglutide |
| publisher |
Frontiers Media S.A. |
| publishDate |
2021 |
| url |
https://doaj.org/article/1d6095bb78274de5a98922ae3f3ed6df |
| work_keys_str_mv |
AT markmsmits corrigendumsafetyofsemaglutide AT danielhvanraalte corrigendumsafetyofsemaglutide |
| _version_ |
1718439848449146880 |